Publications

Export 8 results:
Sort by: [ Author (Asc)] Title Type Year
Filters: Keyword is Administration, Oral  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
B
Baillie JK, Thompson AA, Irving JB, Bates MG, Sutherland AI, Macnee W, et al. Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial. QJM. 2009;102(5):341-8. Abstract
C
Chin CT, Roe MT, Fox KA, Prabhakaran D, Marshall DA, Petitjean H, et al. Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: (TRILOGY ACS) trial. Am Heart J. 2010;160(1):16-22.e1. Abstract
Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Gray GA, et al. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 1993;365(6448):759-61. Abstract
Clozel M, Breu V, Gray GA, Kalina B, Löffler BM, Burri K, et al. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther. 1994;270(1):228-35. Abstract
M
Macintyre IM, Dhaun N, Lilitkarntakul P, Melville V, Goddard J, Webb DJ. Greater functional ETB receptor antagonism with bosentan than sitaxsentan in healthy men. Hypertension. 2010;55(6):1406-11. Abstract
O
Oliver JJ, Dear JW, Webb DJ. Clinical potential of combined organic nitrate and phosphodiesterase type 5 inhibitor in treatment-resistant hypertension. Hypertension. 2010;56(1):62-7. Abstract
P
Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883-91. Abstract
R
Rosenstock J, Banarer S, Fonseca VA, Inzucchi SE, Sun W, Yao W, et al. The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy. Diabetes Care. 2010;33(7):1516-22. Abstract